Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients-Reference-Cited by-同舟云学术

Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients

Published:1995-12 Issue:1-2 Volume:202 Page:17-20
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Blum-Degena Doris,Müller Thomas,Kuhn Wilfried,Gerlach Manfred,Przuntek Horst,Riederer Peter

Publisher

Elsevier BV

Subject

General Neuroscience

Reference39 articles.

1. Interleukin-6 and a-2macroglobulin indicate an acute-phase state in Alzheimer's disease cortices;Bauer;FEBS Lett.,1991

2. Stimulation of oligodendroglial proliferation and maturation by interleukin-2;Benveniste;Nature,1986

3. Lymphokine production in patients with Alzheimer's disease;Bessler;Age Ageing,1989

4. Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders;Cacabelos;Methods Find. Exp. Clin. Pharmacol.,1991

5. Investigations on auto-antibodies in Alzheimer's and Parkinson's disease using defined neuronal cultures;Dahlström;J. Neural Transm.,1990

Cited by 689 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The genetic advantage of healthy centenarians: unraveling the central role of NLRP3 in exceptional healthspan;Frontiers in Aging;2024-09-05

2. Differentiation and regulation of CD4+ T cell subsets in Parkinson’s disease;Cellular and Molecular Life Sciences;2024-08-17

3. Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders;Frontiers in Pharmacology;2024-07-30

4. PKCδ serves as a potential biomarker and therapeutic target for microglia‐mediated neuroinflammation in Alzheimer's disease;Alzheimer's & Dementia;2024-06-28

5. KLOTHO KL‐VS heterozygosity is associated with diminished age‐related neuroinflammation, neurodegeneration, and synaptic dysfunction in older cognitively unimpaired adults;Alzheimer's & Dementia;2024-06-21